NYSE · CHGCY
Healthcare · Drug Manufacturers - General
$21.15
Up+$0.17 (+0.81%)
Updated Oct 30, 2026, 12:08 PM
SID Score
6.1/10
Composite research score
Smart Money
46/100
Neutral
Price performance · CHGCY
1M range · 0 trading sessions · Daily adjusted prices
CHGCY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning CHGCY.
Company
Market Activity
Research & News
CHGCY research
Company profile and research snapshot.
CHUGAI PHARM UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Oct 22, 2026
Rani Therapeutics (NASDAQ:RANI) outlined progress for its oral biologics delivery platform, including plans to advance its obesity program RT-114 and expectations for additional milestones from its collaboration with Chugai. Chief Executive Officer Talat Imran said the clinical-stage biotechnology
Yahoo · Oct 5, 2026
In September 2026, Chugai Pharmaceutical reported that Roche will discontinue development of the anti-latent myostatin antibody emugrobart for obesity and return all rights, after interim Phase II data suggested clinically meaningful weight loss targets were unlikely to be met despite a favorable safety profile. With those rights now back in-house, Chugai is preparing to restart development of emugrobart for spinal muscular atrophy and is exploring out-licensing, reshaping how this asset...
Yahoo · Sep 29, 2026
Asian stock markets largely fell back Tuesday as oil prices and bond yields remain firm at relativel
Yahoo · Sep 26, 2026
Japanese government bond yields have hit a 30‑year high, putting pressure on risk assets while pushing investors to look harder for growth themes with clear, real world use cases. Healthcare powered by artificial intelligence in Japan sits at the intersection of those needs and opportunities. This article introduces three AI focused healthcare stocks from our screener that investors may wish to evaluate as they consider that shift. The three stocks highlighted below are only a small sample of...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CHGCY.
